Table 2 Prescription of anti-rheumatic therapy among patients with different levels of education
Treatment | Without degree, number (%) | With degree, number (%) | Crude p values, from Chi square test | Adjusted p values* |
|---|---|---|---|---|
Treatment initiated at the diagnosis (baseline) | ||||
DMARDs | 2004 (86.8) | 606 (85.2) | 0.30 | 0.44 |
NSAIDs | 1153 (49.9) | 384 (54.0) | 0.06 | 0.10 |
Cortisone | 946 (41.0) | 276 (38.8) | 0.32 | 0.69 |
Biologics | 145 (6.3) | 32 (4.5) | 0.08 | 0.08 |
3-month visit | ||||
DMARDs | 1642 (90.7) | 518 (89.8) | 0.52 | 0.59 |
NSAIDs | 699 (38.6) | 241 (41.8) | 0.17 | 0.10 |
Cortisone | 736 (40.6) | 242 (41.9) | 0.58 | 0.47 |
Biologics | 186 (10.3) | 52 (9.0) | 0.38 | 0.27 |
6-month visit | ||||
DMARDs | 1435 (90.4) | 409 (90.3) | 0.93 | 0.56 |
NSAIDs | 558 (35.2) | 165 (36.4) | 0.62 | 0.26 |
Cortisone | 606 (38.2) | 173 (38.2) | 0.99 | 0.89 |
Biologics | 203 (12.8) | 56 (12.4) | 0.81 | 0.42 |
1-year visit | ||||
DMARDs | 1807 (87.7) | 553 (87.5) | 0.91 | 0.33 |
NSAIDs | 660 (32.0) | 190 (30.1) | 0.35 | 0.82 |
Cortisone | 711 (34.5) | 223 (35.3) | 0.72 | 0.86 |
Biologics | 357 (17.3) | 120 (19.0) | 0.34 | 0.65 |